Overview
- 19 inspections across 19 sites are on record.
- 47 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-07.
At a glance
Inspections
19
Sites
19
Observations
47
Career since
Aug 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| ChemPacific Corporation | 7 Apr 2026 | Human Drugs | On file |
| New Life Pharma LLC | 13 Feb 2026 | Human Drugs | View 483 → |
| Carnegie Pharmaceuticals, LLC | 31 Oct 2025 | Human Drugs | |
| Holland Company, Inc. | 24 Sep 2025 | Human Drugs | |
| University Of Pittsburgh Medical Center Centralized Packaging | 14 Aug 2025 | Human Drugs | On file |
Sites inspected
ChemPacific CorporationBaltimore, United States1 insp.
New Life Pharma LLCNorthvale, United States1 insp.
Carnegie Pharmaceuticals, LLCDelran, United States1 insp.
Holland Company, Inc.Adams, United States1 insp.
University Of Pittsburgh Medical Center Centralized PackagingPittsburgh, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Pushpa S Jayasekara3 shared
Azeezat M Lawal3 shared
Tekalign Wondimu3 shared
Stephenie M Ortiz2 shared
Ogechi C Nna2 shared
Christina K Theodorou2 shared
Johnny D Nwankwo2 shared
Michael O Idowu1 shared
Annet R Rajan1 shared
Anthony J Donato1 shared
Full investigator report
Get the verbatim findings behind Yaharn Su's 47 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site